Skip to main content Skip to footer
  • "com.cts.aem.core.models.NavigationItem@2c74b40b" Careers
  • "com.cts.aem.core.models.NavigationItem@55b0076e" News
  • "com.cts.aem.core.models.NavigationItem@72efd3bf" Events
  • "com.cts.aem.core.models.NavigationItem@285f5cbb" Investors
Case study

The challenge

Life sciences companies have many regulatory responsibilities, including the obligation to document and maintain consumer feedback on the safety and efficacy of their products.

At this life sciences company, that obligation was increasing exponentially, with the volume of individual case safety reports (ICSRs) doubling year over year.

Our approach

The immediate goal of the project was to replace and automate repetitive manual activities with a zero-touch robotic process automation (RPA) solution for the processing of ICSRs submitted by consumers and monitored by pharmaceutical industry regulators.

In developing the RPA solution, however, we recognized that it could be a first step toward introducing automation in other areas of the organization. The RPA solution was completed and went live in just seven months. New automation efforts are in development to incorporate areas where more complex processing is needed, along with certain cognitive elements, including artificial intelligence and machine learning.

RPA improves efficiency, consistency and quality

The RPA solution delivers numerous benefits, including faster processing with greater consistency and fewer errors. More important, its modular design can be customized and scaled for future needs in other types of documents and transmission modes.

30%

reduction in end-to-end cycle time

99%

first-time accuracy achieved

96%

regulatory compliance attained

92%

turnaround time compliance reached